Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RIPK1-IN-7 is a potent and selective inhibitor of RIPK1(Kd of 4 nM and an enzymatic IC50 of 11 nM),andexhibits excellent antimetastasis activity in the experimental B16 melanoma lung metastasis model.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 175.00 | |
5 mg | In stock | $ 372.00 | |
10 mg | In stock | $ 556.00 | |
25 mg | In stock | $ 896.00 | |
50 mg | In stock | $ 1,220.00 | |
100 mg | In stock | $ 1,650.00 | |
500 mg | In stock | $ 3,290.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 393.00 |
Description | RIPK1-IN-7 is a potent and selective inhibitor of RIPK1(Kd of 4 nM and an enzymatic IC50 of 11 nM),andexhibits excellent antimetastasis activity in the experimental B16 melanoma lung metastasis model. |
Targets&IC50 | RIPK1:(kd)4 nM , RIPK1:11 nM |
In vitro | In the TSZ-induced HT29 cell necroptosis model, RIPK1-IN-7 shows potent cell protection effect (EC50 of 2nM). RIPK1-IN-7 displays considerable activity against several other kinases(Flt4, TrkA, TrkB, TrkC, Axl, HRI, Mer, and MAP4K5 with IC50s of 20, 26, 8, 7, 35, 26, 29, and 27 nM, respectively). |
Molecular Weight | 481.47 |
Formula | C25H22F3N5O2 |
CAS No. | 2300982-44-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (124.62 mM), sonification is recommended.
H2O: 0.1 mg/mL (insoluble)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RIPK1-IN-7 2300982-44-7 Apoptosis NF-Κb RIP kinase RIPK-1-IN-7 inhibit TrkA Mer Receptor-interacting protein kinases Flt4 Axl TrkB Inhibitor RIPK TrkC RIPK1 IN 7 RIPK1IN7 HRI inhibitor